Embecta director sells 6,293 shares at $5.875
Embecta director Morris Milton Mayo disclosed a single open-market sale of 6,293 EMBC shares, leaving him with about 53.8 thousand shares directly held.
Rhea-AI Filing Summary
Embecta Corp. (EMBC) director Morris Milton Mayo reported selling 6,293 shares of Embecta common stock on September 4, 2026 in an open-market or private transaction at $5.875 per share. Following this sale, he directly holds 53,828.34 shares of Embecta common stock. No Rule 10b5-1 trading plan is reported for this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 6,293 shares
Net Sell
1 txn
Insider
Morris Milton Mayo
Role
Director
Sold
6,293 shs ($37K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,293 | $5.875 | $37K |
Holdings After Transaction:
Common Stock — 53,828.34 shares (Direct)
Key Figures
Shares sold: 6,293 shares
Sale price per share: $5.875 per share
Shares held after transaction: 53,828.34 shares
3 metrics
Shares sold
6,293 shares
Common stock sale reported for September 4, 2026
Sale price per share
$5.875 per share
Price for the 6,293 EMBC shares sold
Shares held after transaction
53,828.34 shares
Direct ownership of Embecta common stock after the sale
Key Terms
Rule 10b5-1, open-market or private transaction
2 terms
Rule 10b5-1 regulatory
"Plan status shows no Rule 10b5-1 plan is reported for this sale"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open-market or private transaction financial
"Described as a sale in an open-market or private transaction"
FAQ
What insider transaction did EMBC director Morris Milton Mayo report?
He reported a sale of 6,293 shares of Embecta common stock on September 4, 2026 in an open-market or private transaction at $5.875 per share.
Was the EMBC insider sale made under a Rule 10b5-1 trading plan?
No. The filing indicates no Rule 10b5-1 trading plan is associated with this transaction; the document-level Rule 10b5-1 checkbox is not checked.
Is this EMBC Form 4 focused on derivative securities or common stock?
This Form 4 reports a transaction in Embecta common stock only. The derivative section shows no derivative positions or transactions in this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.